Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E31.20 EPS (ttm)1.90 Insider Own0.03% Shs Outstand2.88B Perf Week-1.66%
Market Cap171.00B Forward P/E16.54 EPS next Y3.59 Insider Trans4.59% Shs Float2.87B Perf Month-0.65%
Income5.61B PEG7.75 EPS next Q0.89 Inst Own75.60% Short Float0.85% Perf Quarter2.05%
Sales43.55B P/S3.93 EPS this Y-26.50% Inst Trans-1.24% Short Ratio2.98 Perf Half Y6.73%
Book/sh16.58 P/B3.58 EPS next Y2.78% ROA5.40% Target Price62.61 Perf Year28.51%
Cash/sh4.64 P/C12.77 EPS next 5Y4.03% ROE11.50% 52W Range43.23 - 60.98 Perf YTD21.15%
Dividend1.76 P/FCF32.81 EPS past 5Y-16.50% ROI6.60% 52W High-3.15% Beta0.42
Dividend %2.97% Quick Ratio1.50 Sales past 5Y13.00% Gross Margin60.20% 52W Low36.62% ATR0.74
Employees77300 Current Ratio1.90 Sales Q/Q-0.70% Oper. Margin18.60% RSI (14)45.51 Volatility1.37% 1.21%
OptionableYes Debt/Eq0.48 EPS Q/Q126.70% Profit Margin12.90% Rel Volume1.30 Prev Close59.28
ShortableYes LT Debt/Eq0.38 EarningsOct 27 BMO Payout90.60% Avg Volume8.20M Price59.06
Recom2.50 SMA20-1.59% SMA500.66% SMA2006.24% Volume1,154,926 Change-0.37%
30-Apr-14Reiterated Argus Buy $62 → $66
11-Apr-14Reiterated MKM Partners Buy $64 → $70
05-Feb-14Reiterated Argus Buy $54 → $62
14-Jan-14Reiterated MKM Partners Buy $59 → $64
03-Jun-13Reiterated MKM Partners Buy $54 → $59
15-Apr-13Reiterated Barclays Overweight $45 → $60
04-Feb-13Reiterated MKM Partners Buy $51 → $52
04-Feb-13Reiterated Barclays Overweight $46 → $45
20-Nov-12Upgrade MKM Partners Neutral → Buy $47 → $51
17-Oct-12Reiterated MP Advisors Outperform $45 → $50
30-Jul-12Reiterated UBS Buy $45 → $50
13-Jul-12Upgrade MP Advisors Market Perform → Outperform $45
03-Feb-12Reiterated Barclays Capital Overweight $38 → $40
03-Feb-12Downgrade MKM Partners Buy → Neutral $42 → $40
29-Nov-11Initiated MKM Partners Buy $38
14-Sep-11Reiterated Barclays Capital Overweight $41 → $38
16-May-11Reiterated UBS Buy $40 → $42
04-Feb-11Reiterated UBS Buy $42 → $40
24-Jan-11Reiterated Deutsche Bank Buy $48 → $43
24-Jan-11Reiterated Barclays Capital Overweight $43 → $41
30-Sep-14 12:02PM  J&J Buying Alios, Going Up Against Gilead at Investor's Business Daily
07:45AM  1 year later: Buy stocks booted from the Dow? Yahoo Finance
29-Sep-14 04:19PM  Indian Prime Minister courts U.S. CEOs at MarketWatch
02:16PM  Business events scheduled for Tuesday AP
01:31PM  Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader Benzinga
11:14AM  Cancer drug stocks on the move amid striking data at CNBC
09:00AM  Merck Partners with eSSENTIAL Accessibility to offer app for people with disabilities CNW Group
05:00AM  MSD Announces First Presentation of Early Data on the Investigational Use of Pembrolizumab in Patients with Advanced Bladder Cancer at ESMO 2014 Business Wire
05:00AM  Merck immunotherapy drug shows promise in bladder cancer Reuters
05:00AM  Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA┬« (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014 Business Wire
28-Sep-14 03:15AM  MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at ESMO 2014 Business Wire
03:15AM  Merck drug extends immune system fight to stomach cancer Reuters
03:15AM  Merck Announces First Presentation of Data on the Investigational Use of KEYTRUDA┬« (pembrolizumab) in Patients with Advanced Gastric Cancer at ESMO 2014 Business Wire
26-Sep-14 05:08PM  Bristol immunotherapy gets 6-month U.S. FDA review for melanoma Reuters
12:58PM  FMHR Final Trade: MRK, NCR & more CNBC
12:58PM  [video] FMHR Final Trade: MRK, NCR & more at CNBC
12:00PM  Dow Jones (DJIA) Today: Merck (MRK) Lower at TheStreet
24-Sep-14 11:37PM  Top 100 Richest Indians: India's Pharma Sector Mints Billionaires at Forbes
05:29PM  Gilead's New HIV Drug Key To Long-Term Strategy at Investor's Business Daily
05:00PM  Merck to Hold Third-Quarter 2014 Sales and Earnings Conference Call on October 27 Business Wire
23-Sep-14 04:19PM  Stocks fall amid global concerns; small caps hit again at CNBC
04:00PM  Stocks fall amid global concerns; small caps hit again at CNBC
03:16PM  S&P 500 extends drop into 3rd day; Dow falls 100 pts at CNBC
02:27PM  S&P 500 extends drop into 3rd day; Dow falls 100 pts at CNBC
02:00PM  S&P 500 extends drop into 3rd day; Dow falls 100 pts at CNBC
12:59PM  S&P 500 extends losses into third session at CNBC
12:52PM  Siemens U.S. Deal Hands Kaeser Second Win Over Ex-Boss at Bloomberg
11:42AM  S&P 500 extends losses into third session at CNBC
10:42AM  Nasdaq, S&P 500 extend losses into third session at CNBC
10:16AM  US stocks mixed after Obama speaks on airstrikes at CNBC
09:57AM  Stocks ease losses; Nasdaq turns positive at CNBC
08:00AM  Merck KGaA Records the Largest Acquisition in Their History at $17 Billion (Revised) Zacks
03:17AM  [video] German Companies Splurge on U.S. Deals at Bloomberg
01:35AM  [$$] Germany's Merck Buys New Tools to Aid Performance at The Wall Street Journal
22-Sep-14 06:01PM  Your first trade for Tuesday at CNBC
05:27PM  Stocks end lower: Nasdaq off more than 1% at USA TODAY
05:21PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
05:07PM  [video] Sigma-Aldrich Surges as Merck Makes Multibillion-Dollar Offer at TheStreet
04:37PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
04:33PM  Stocks end lower: Nasdaq off more than 1% at USA TODAY
03:10PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
02:57PM  [video] Rockefeller Family Divesting From Oil, and More at MarketWatch
02:25PM  Siemens to Merck Join German Rush to Make U.S. Deals at Bloomberg
01:58PM  Business events scheduled for Tuesday AP
01:44PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
01:43PM  Merck KGaA: Adrenalin shot at Financial Times
01:38PM  [$$] Germany's Merck Buys New Tools to Aid Performance at The Wall Street Journal
01:24PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
01:21PM  Your first trade for Tuesday at CNBC
01:16PM  Why Jim Cramer Says Dresser-Rand (DRC), Sigma-Aldrich (SIAL), TRW (TRW) Acquisitions Are Important at TheStreet
12:10PM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
10:27AM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
10:17AM  Germany's Merck to buy Sigma-Aldrich for $17 billion Reuters
09:56AM  [$$] Germany's Merck to Buy Sigma-Aldrich at The Wall Street Journal
09:41AM  Merck KGaA to Buy Sigma-Aldrich for $17B to Add Chemicals Bloomberg
09:41AM  Merck KGaA to Buy Sigma-Aldrich for $17 Billion to Add Chemicals Bloomberg
09:22AM  [$$] Germany's Merck to Buy Sigma-Aldrich for $17 Billion at The Wall Street Journal
09:03AM  German Merck to buy St. Louis-based Sigma-Aldrich AP
08:45AM  German Merck to buy St. Louis-based Sigma-Aldrich AP
08:38AM  Merck KGaA to buy Sigma-Aldrich for $17 billion Reuters
08:32AM  Merck KGaA to Buy Sigma-Aldrich for $17B to Add Chemicals Bloomberg
08:10AM  Merck KGaA to buy Sigma-Aldrich for $17 billion Reuters
08:08AM  German Merck to buy St. Louis-based Sigma-Aldrich AP
07:33AM  Merck KGaA to buy Sigma-Aldrich for $17 billion Reuters
07:11AM  German Merck to buy St. Louis-based Sigma Aldrich AP
07:07AM  Merck KGaA to Buy Sigma-Aldrich for $17B to Add Chemicals Bloomberg
07:00AM  [$$] Germany's Merck to Buy Sigma-Aldrich for $17 Billion at The Wall Street Journal
06:45AM  Merck KGaA to buy Sigma-Aldrich for $17 billion Reuters
06:44AM  Merck to buy US's Sigma-Aldrich for $17bn at Financial Times
06:31AM  Merck of Germany to Acquire Sigma-Aldrich for $17 Billion at New York Times
06:09AM  Merck KGaA to Buy Sigma-Aldrich for to Add Chemicals at Bloomberg
06:09AM  Merck KGaA to Buy Sigma-Aldrich for $17B to Add Chemicals Bloomberg
19-Sep-14 01:50PM  Is Merck KGaA on Track with its "Fit for 2018" Program? Zacks
11:30AM  Alibaba's IPO debut delayed two hours on 1st day of trading at USA TODAY
11:09AM  Alibaba's IPO debut delayed two hours on 1st day of trading at USA TODAY
11:00AM  Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal PR Newswire
10:33AM  Alibaba's IPO debut delayed on first day of trading at USA TODAY
09:40AM  Dow 30 Stock Roundup: Boeing to Receive $4.2B Contract from NASA, Cisco to Acquire Metacloud Zacks
18-Sep-14 06:00PM  Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer Zacks
04:56PM  Bayer Deal for Zoetis in Sight After Unit Sale: Real M&A at Bloomberg
03:55PM  Merck Enters into Licensing Agreement with Sun Pharma Zacks
08:15AM  Credit Suisse Gold Standard Yield Stocks May Be the Safest to Own Now 24/7 Wall St.
07:36AM  Bayer to float plastics business and focus on life sciences at Financial Times
06:12AM  Merck KGaA seeks partner for immuno-oncology drug by year-end Reuters
06:01AM  Bayer to Spin Off Polymer Business in Public Listing at New York Times
17-Sep-14 06:15PM  Merck Posts Positive Data on Osteoporosis Drug Odanacatib Zacks
11:10AM  Sun Pharma licenses Merck psoriasis drug for $80M AP
10:12AM  Merck licenses experimental psoriasis drug to India's Sun Pharma Reuters
10:00AM  Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Leads The Day Higher, Merck (MRK) Lags at TheStreet
09:31AM  Merck Presents First Phase 3 Data in Japanese Patients for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes Business Wire
08:30AM  Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab Business Wire
16-Sep-14 06:30PM  Urine test for cervical cancer virus offers alternative to smear Reuters
03:14PM  Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets Zacks
02:00PM  Dow Jones (DJIA) Today: Merck (MRK) Higher at TheStreet
08:10AM  What Ralph Nader Gets Wrong About Big Pharma at Forbes
08:10AM  Ralph Nader Has Set His Sights On Big Pharma -- And He Misses Opportunity at Forbes
06:35AM  Ebola under the microscope CNBC
03:16AM  AstraZeneca gets up to $500 mln from Lilly for Alzheimer's drug Reuters
15-Sep-14 04:51PM  Merck osteoporosis drug passes trial, but side effects hover Reuters
02:42PM  Merck KGaA Stops All Tecemotide Studies for Lung Cancer Zacks
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEOSep 10Option Exercise34.2012,875440,272348,379Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOSep 10Sale60.489,814593,592338,565Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM